(Q35006900)

5 August 2017

title

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (English)

1 reference

5 August 2017

1 reference

1 reference

William David Foulkes

11

object named as

W D Foulkes

1 reference

5 August 2017

14

S A Narod

1 reference

5 August 2017

K Metcalfe

1

1 reference

5 August 2017

S Gershman

2

1 reference

5 August 2017

H T Lynch

3

1 reference

5 August 2017

P Ghadirian

4

1 reference

5 August 2017

N Tung

5

1 reference

5 August 2017

C Kim-Sing

6

1 reference

5 August 2017

O I Olopade

7

1 reference

5 August 2017

S Domchek

8

1 reference

5 August 2017

J McLennan

9

1 reference

5 August 2017

A Eisen

10

1 reference

5 August 2017

B Rosen

12

1 reference

5 August 2017

P Sun

13

1 reference

5 August 2017

language of work or name

English

0 references

publication date

12 April 2011

1 reference

British Journal of Cancer

5 August 2017

published in

1 reference

5 August 2017

volume

104

1 reference

5 August 2017

issue

9

1 reference

5 August 2017

page(s)

1384-1392

1 reference

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Age at menarche and menopause and breast cancer risk in the International BRCA1/2 Carrier Cohort Study.

8 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.120

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.120

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.120

Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.120

BRCA-associated breast cancer in young women

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101934

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21487411

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21487411

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.2011.120

1 reference

5 August 2017

1 reference

5 August 2017

1 reference